Anavex Life Sciences
AVXL
#7563
Rank
C$0.54 B
Marketcap
C$6.08
Share price
-1.12%
Change (1 day)
-42.96%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): C-$0.80

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is C-$0.79. In 2024 the company made an earnings per share (EPS) of C-$0.72 an increase over its 2023 EPS that were of C-$0.83.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$0.8010.96%
2024C-$0.72-13.33%
2023C-$0.83-3.23%
2022C-$0.8614.81%
2021C-$0.7520%
2020C-$0.62-16.67%
2019C-$0.7538.46%
2018C-$0.5418.18%
2017C-$0.46-21.43%
2016C-$0.58-35.38%
2015C-$0.90-36.27%
2014C-$1.41112.5%
2013C-$0.66-58.62%
2012C-$1.60-0%
2011C-$1.60-29.27%
2010C-$2.2751.85%
2009C-$1.49-0%
2008C-$1.49237.5%
2007C-$0.44
2006N/A-100%
2005C-$0.05526499.97%
2004C-$0.009210

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
C$3.30-519.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
C-$0.06908-91.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
C$1.38-275.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
C-$84.27 10,601.75%๐Ÿ‡บ๐Ÿ‡ธ USA